Literature DB >> 32443942

Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now.

Julia K Mader1.   

Abstract

Entities:  

Keywords:  COVID-19; diabetes management; telemedicine

Mesh:

Substances:

Year:  2020        PMID: 32443942      PMCID: PMC7673167          DOI: 10.1177/1932296820930289

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


× No keyword cloud information.
  8 in total

1.  128 SHADES OF RED: Objective Remote Assessment of Radiation Dermatitis by Augmented Digital Skin Imaging.

Authors:  Richard Partl; Beata Jonko; Stefan Schnidar; Michael Schöllhammer; Max Bauer; Sanchit Singh; Julia Simeckova; Kathrin Wiesner; Andreas Neubauer; Harald Schnidar
Journal:  Stud Health Technol Inform       Date:  2017

2.  A new imaging and data transmitting device for telemonitoring of diabetic foot syndrome patients.

Authors:  Piotr Foltynski; Piotr Ladyzynski; Karolina Migalska-Musial; Stanislawa Sabalinska; Anna Ciechanowska; Jan Wojcicki
Journal:  Diabetes Technol Ther       Date:  2011-05-13       Impact factor: 6.118

3.  Incorporating telemedicine as part of COVID-19 outbreak response systems.

Authors:  Kimberly Lovett Rockwell; Alexis S Gilroy
Journal:  Am J Manag Care       Date:  2020-04       Impact factor: 2.229

4.  Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials.

Authors:  Huidi Tchero; Pauline Kangambega; Christine Briatte; Solenne Brunet-Houdard; Gerald-Reparate Retali; Emmanuel Rusch
Journal:  Telemed J E Health       Date:  2018-08-20       Impact factor: 3.536

5.  Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities.

Authors:  Satish K Garg; David Rodbard; Irl B Hirsch; Gregory P Forlenza
Journal:  Diabetes Technol Ther       Date:  2020-04-17       Impact factor: 6.118

6.  WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): from bedside to phone-side.

Authors:  D Jakhar; S Kaul; I Kaur
Journal:  Clin Exp Dermatol       Date:  2020-05-02       Impact factor: 4.481

Review 7.  Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.

Authors:  Amerta Ghosh; Ritesh Gupta; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-04-04

8.  Using Telehealth as a Tool for Rural Hospitals in the COVID-19 Pandemic Response.

Authors:  Jeydith Gutierrez; Ethan Kuperman; Peter J Kaboli
Journal:  J Rural Health       Date:  2020-06-01       Impact factor: 5.667

  8 in total
  5 in total

Review 1.  Overview of Technologies Implemented During the First Wave of the COVID-19 Pandemic: Scoping Review.

Authors:  Alaa Abd-Alrazaq; Asmaa Hassan; Israa Abuelezz; Arfan Ahmed; Mahmood Saleh Alzubaidi; Uzair Shah; Dari Alhuwail; Anna Giannicchi; Mowafa Househ
Journal:  J Med Internet Res       Date:  2021-09-14       Impact factor: 5.428

2.  Effect of the COVID-19 quarantine on metabolic control in children and adolescents with type 1 diabetes.

Authors:  Hande Turan; Didem Güneş Kaya; Gürkan Tarçın; Saadet Olcay Evliyaoğlu
Journal:  Endocrinol Diabetes Nutr (Engl Ed)       Date:  2022-03       Impact factor: 1.417

3.  Self-Care of Adults with Type 2 Diabetes During the COVID-19 Pandemic: A Qualitative Interpretive Description Study.

Authors:  Michela Luciani; Camilla Bigoni; Marta Canesi; Matteo Masotto; Diletta Fabrizi; Stefania Di Mauro; Davide Ausili
Journal:  Clin Nurs Res       Date:  2022-10-05       Impact factor: 1.724

4.  Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study.

Authors:  Wenwen Yin; Yawen Liu; Hao Hu; Jin Sun; Yuanyuan Liu; Zhaoling Wang
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

5.  Effect of the COVID-19 quarantine on metabolic control in children and adolescents with type 1 diabetes.

Authors:  Hande Turan; Didem Güneş Kaya; Gürkan Tarçın; Saadet Olcay Evliyaoğlu
Journal:  Endocrinol Diabetes Nutr (Engl Ed)       Date:  2021-06-08       Impact factor: 1.417

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.